Stimulant Medications and Heart Risks
All ADHD stimulant drugs carry warnings that they should not be used by patients with structural heart problems or pre-existing heart conditions (high blood pressure, heart failure, heart rhythm disturbances, or congenital heart disease). These drugs have been associated with sudden death in children with heart problems. They have also been associated with sudden death, stroke, and heart attack in adults with a history of heart disease. The...
Read moreLast week I wrote a post entitled, "Why Some People Don't Believe in ADHD" which generated a lot of discussion among our members on ADHD... Read more »
What are some of the common symptoms of ADHD in adults? Most information is written on children with ADHD, however, it is now known... Read more »
If a child has ADHD there's better than a 1 in 2 chance that he or she will continue to have the disorder into adulthood. Impulsivity,... Read more »
You think you have ADHD. You have struggled throughout your life with paying attention and focusing. You have a need to be constantly... Read more »
Over the past 30 years as inpatient and outpatient mental health services decreased across the United States, more and more adults and... Read more »
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414... Read more »
Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication.... Read more »
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
This study will evaluate the optimal dosing of Vyvanse in kids with attention-deficit/hyperactivity disorder. Researchers want to know the efficacy,... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »